Lipid Disorders
News
FDA advisory committee supports new CV liraglutide indication
A Food and Drug Administration advisory committee voted 17-2 in support of a supplemental new drug application for liraglutide (Victoza)...
Conference Coverage
SPRINT: Intensive BP control cut cardiovascular risk in patients with prediabetes
SAN DIEGO – Dropping systolic BP to 120 mm Hg may prevent cardiac events in people with prediabetes.
Conference Coverage
DURATION-8: Exenatide/dapagliflozin efficacy holds up at 1 year
SAN DIEGO – Uncontrolled type 2 diabetes may have met its match.
From the Journals
Coconut oil and dairy fats pose similar CVD risk
Coconut oil is all the rage, but should it be?
Conference Coverage
CANVAS: Canagliflozin cuts cardiovascular events, doubles risk of amputations
SAN DIEGO – Would you accept this trade-off: Lower risk for MI, greater risk for amputation?
Conference Coverage
Providers buck lipid recommendations in high-risk diabetes
SAN DIEGO – When the ADA issues diabetes care guidelines, does anyone listen?
Conference Coverage
Liraglutide produced cardiometabolic benefits in patients with schizophrenia
SAN DIEGO – Can the cardiometabolic risk factors associated with the use of some antipsychotic medications be prevented?
Conference Coverage
BIO-RESORT: A mandate to prescreen PCI patients for silent diabetes
PARIS – Unsuspected abnormal glucose tolerance can provoke periprocedural complications.
From the Journals
For Americans, less salt is still too much
Sodium content of packaged food is down since 2000, but most households still purchase above-optimal amounts of salt.
From the Journals
Framingham: Arterial stiffening not inevitable with aging
Framingham heart study longitudinal finding flies in the face of long-held clinical belief about aging.
From the Journals
Gastric bands hit with high reoperation rates, rising costs
A study finds the laparoscopic adjustable gastric band may be more trouble than it is worth.